Z16.3
Resistance to other antimicrobial drugs
Clinical Classification Guidelines
Excludes Type 1
- resistance to antibiotics (Z16.1-, Z16.2-)
Medical Intelligence & Overview
ICD-10 code Z16.3 pertains to resistance to other antimicrobial drugs, a situation where bacteria or other microorganisms are no longer affected by certain medications used to treat infections. Antimicrobial resistance (AMR) is a significant global health concern because it can lead to infections that are difficult to treat, increased medical costs, and higher risks of complications. This classification helps healthcare providers document and track cases where resistance to specific drugs complicates treatment plans.
Causes & Symptoms
Clinical Causes: Overuse or misuse of antibiotics and other antimicrobial agents Incomplete courses of treatment, leading to surviving resistant organisms Use of antibiotics in agriculture and animal husbandry Presence of resistant strains in healthcare environments Transmission of resistant bacteria between individuals and communities
Key Symptoms: Persistent or worsening infection symptoms despite treatment Fever and chills that do not resolve with standard therapy Unusual or resistant bacterial cultures in laboratory tests Extended illness duration Repeated infections or relapses
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves laboratory testing of samples from the infected area. Microbiological cultures are analyzed to identify the microorganism and determine its susceptibility or resistance to specific antimicrobial drugs. This helps healthcare providers choose effective treatment options and confirm resistance patterns associated with the infection.
Treatment Protocols: Treating antimicrobial resistance often requires alternative or combination therapies, guided by laboratory results. In some cases, healthcare providers may recommend reviewing and adjusting medication strategies. Additionally, infection control measures in healthcare settings play a crucial role in preventing the spread of resistant organisms. It is essential to limit unnecessary antibiotic use and ensure adherence to prescribed regimens to reduce the development of resistance.
Clinical Advice & FAQs
Billing Guidance
Is Z16.3 a billable ICD-10 code?
Yes, Z16.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z16.3?
Clinical documentation must specify the nature of Resistance to other antimicrobial drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference